Here, we describe for the first time that loss of the KMT2C methyltransferase domain accelerates tumour growth and promotes a switch from indolent to lethal, metastatic disease in vivo when combined with other PCa associated mutational events, specifically loss of PTEN. The gene discussed is PTEN; the disease is neoplasm.